These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29987409)

  • 1. Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds.
    Karhu ST; Välimäki MJ; Jumppanen M; Kinnunen SM; Pohjolainen L; Leigh RS; Auno S; Földes G; Boije Af Gennäs G; Yli-Kauhaluoma J; Ruskoaho H; Talman V
    Arch Toxicol; 2018 Sep; 92(9):2897-2911. PubMed ID: 29987409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
    Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
    Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators.
    Jumppanen M; Kinnunen SM; Välimäki MJ; Talman V; Auno S; Bruun T; Boije Af Gennäs G; Xhaard H; Aumüller IB; Ruskoaho H; Yli-Kauhaluoma J
    J Med Chem; 2019 Sep; 62(17):8284-8310. PubMed ID: 31431011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds.
    Witt G; Keminer O; Leu J; Tandon R; Meiser I; Willing A; Winschel I; Abt JC; Brändl B; Sébastien I; Friese MA; Müller FJ; Neubauer JC; Claussen C; Zimmermann H; Gribbon P; Pless O
    Cell Biol Toxicol; 2021 Apr; 37(2):229-243. PubMed ID: 32564278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5.
    Välimäki MJ; Tölli MA; Kinnunen SM; Aro J; Serpi R; Pohjolainen L; Talman V; Poso A; Ruskoaho HJ
    J Med Chem; 2017 Sep; 60(18):7781-7798. PubMed ID: 28858485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dural effects of oxidative stress on cardiomyogenesis via Gata4 transcription and protein ubiquitination.
    Li T; Zhang X; Jiang K; Liu J; Liu Z
    Cell Death Dis; 2018 Feb; 9(2):246. PubMed ID: 29445146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds.
    Lu HR; Whittaker R; Price JH; Vega R; Pfeiffer ER; Cerignoli F; Towart R; Gallacher DJ
    Toxicol Sci; 2015 Dec; 148(2):503-16. PubMed ID: 26358003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Cyclodextrin induces the differentiation of resident cardiac stem cells to cardiomyocytes through autophagy.
    Shi X; Li W; Liu H; Yin D; Zhao J
    Biochim Biophys Acta Mol Cell Res; 2017 Aug; 1864(8):1425-1434. PubMed ID: 28522298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays.
    Gilchrist KH; Lewis GF; Gay EA; Sellgren KL; Grego S
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):249-57. PubMed ID: 26232523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of alpha- and beta-adrenergic receptors in cardiomyocyte differentiation from murine-induced pluripotent stem cells.
    Li XL; Zeng D; Chen Y; Ding L; Li WJ; Wei T; Ou DB; Yan S; Wang B; Zheng QS
    Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Protocol for In Vitro High-Throughput Chemical Susceptibility Screening in Differentiating NT2 Stem Cells.
    Menzner AK; Gilbert DF
    Methods Mol Biol; 2017; 1601():61-70. PubMed ID: 28470517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-parameter in vitro screen in human stem cell-derived cardiomyocytes identifies ponatinib-induced structural and functional cardiac toxicity.
    Talbert DR; Doherty KR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Sci; 2015 Jan; 143(1):147-55. PubMed ID: 25304212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models.
    Kraushaar U; Meyer T; Hess D; Gepstein L; Mummery CL; Braam SR; Guenther E
    Expert Opin Drug Saf; 2012 Mar; 11(2):285-98. PubMed ID: 22103746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.
    Kinnunen SM; Tölli M; Välimäki MJ; Gao E; Szabo Z; Rysä J; Ferreira MPA; Ohukainen P; Serpi R; Correia A; Mäkilä E; Salonen J; Hirvonen J; Santos HA; Ruskoaho H
    Sci Rep; 2018 Mar; 8(1):4611. PubMed ID: 29545582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Novel Small-Molecule Inducers of Heme Oxygenase-1 That Protect Human iPSC-Derived Cardiomyocytes from Oxidative Stress.
    Kirby RJ; Divlianska DB; Whig K; Bryan N; Morfa CJ; Koo A; Nguyen KH; Maloney P; Peddibhotla S; Sessions EH; Hershberger PM; Smith LH; Malany S
    J Pharmacol Exp Ther; 2018 Jan; 364(1):87-96. PubMed ID: 29101218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.